'Viruses don't respect borders; world must ensure timely, fair access to vaccines', Pg16

Key Highlights:

• Recent outbreaks of Ebola, Hantavirus, and Nipah virus highlight the increasing regularity of zoonotic infections at the human-animal-environment interface.
• These infections can involve human-to-human transmission, necessitating early detection, infection control, and vaccine preparedness.
• Despite advances, licensed human vaccines are still lacking for several major pathogens, including Bundibugyo Ebola, Nipah virus, and Hantavirus.
• Rapid vaccine development requires strong academia-industry partnerships, leveraging scientific research with industrial-scale capacity.
• The economic model for vaccine development for sporadic diseases is challenging, requiring a shared-risk approach with public funding and advance purchase commitments.
• Global cooperation is crucial to ensure timely and fair access to vaccines, as viruses do not respect national borders.

Zoonotic Outbreaks.jpg

Detailed Insights:

• The ability of diseases like Ebola, Nipah, and Andes Hantavirus to spread human-to-human underscores the urgency for robust public health responses.
• Converting scientific knowledge into deployable vaccines involves complex stages like process development, quality control, clinical trials, and manufacturing.
• Artificial Intelligence (AI) tools are increasingly used to identify vaccine targets, predict immune responses, and optimize trial planning, accelerating development.
• Vaccine platform technologies, such as mRNA vaccines, viral vector vaccines, and recombinant protein systems, can significantly speed up vaccine design once a pathogen's genetic sequence is known.
• The Coalition for Epidemic Preparedness Innovations (CEPI) plays a vital role in funding vaccine development for priority pathogens and aims for a 100 Days Mission to develop new vaccines during outbreaks.
• Conventional large clinical trials are often not feasible for unpredictable outbreaks, necessitating emergency trial designs like ring vaccination studies.
• The lack of commercial incentive for vaccines against rare or geographically limited diseases highlights the need for public responsibility and global stockpiles.
• Addressing vaccine hesitancy through community confidence and accurate information is as critical as scientific advancements for effective outbreak control.
• The WHO Pandemic Agreement aims to enhance global coordination, surveillance, and equitable access to vaccines and treatments during future pandemics.

Key Concepts Involved:

• Zoonotic Infections: Diseases transmitted from animals to humans, often emerging at the interface of human, animal, and environmental health.
• Vaccine Platform Technologies: Methods like mRNA, viral vector, or recombinant protein that allow for rapid vaccine development by adapting a core technology to different pathogens.
• One Health Approach: An integrated, unifying approach recognizing the interconnectedness of human, animal, and environmental health for better public health outcomes.
• Ring Vaccination: A strategy where contacts of an infected individual, and their contacts, are vaccinated to form a protective ring around the case.